キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/24 | 3,600 | 3,600 | 3,550 | 3,575 | +5 | +0.1% | 55,200 |
2024/04/23 | 3,480 | 3,570 | 3,480 | 3,570 | +45 | +1.3% | 39,200 |
2024/04/22 | 3,490 | 3,540 | 3,475 | 3,525 | +105 | +3.1% | 59,300 |
2024/04/19 | 3,445 | 3,470 | 3,385 | 3,420 | -55 | -1.6% | 59,800 |
2024/04/18 | 3,510 | 3,525 | 3,440 | 3,475 | -50 | -1.4% | 46,900 |
2024/04/17 | 3,580 | 3,600 | 3,505 | 3,525 | -90 | -2.5% | 64,200 |
2024/04/16 | 3,620 | 3,640 | 3,595 | 3,615 | -40 | -1.1% | 65,800 |
2024/04/15 | 3,605 | 3,675 | 3,605 | 3,655 | +40 | +1.1% | 77,000 |
2024/04/12 | 3,590 | 3,625 | 3,590 | 3,615 | +35 | +1% | 72,500 |
2024/04/11 | 3,500 | 3,585 | 3,495 | 3,580 | +50 | +1.4% | 75,400 |
2024/04/10 | 3,465 | 3,555 | 3,435 | 3,530 | +60 | +1.7% | 62,000 |
2024/04/09 | 3,450 | 3,475 | 3,450 | 3,470 | +20 | +0.6% | 37,800 |
2024/04/08 | 3,435 | 3,455 | 3,405 | 3,450 | +40 | +1.2% | 60,900 |
2024/04/05 | 3,335 | 3,420 | 3,335 | 3,410 | +90 | +2.7% | 83,100 |
2024/04/04 | 3,385 | 3,385 | 3,320 | 3,320 | -80 | -2.4% | 111,700 |
2024/04/03 | 3,350 | 3,415 | 3,340 | 3,400 | +45 | +1.3% | 72,800 |
2024/04/02 | 3,475 | 3,475 | 3,355 | 3,355 | -110 | -3.2% | 83,000 |
2024/04/01 | 3,530 | 3,530 | 3,455 | 3,465 | -70 | -2% | 53,300 |
2024/03/29 | 3,505 | 3,535 | 3,485 | 3,535 | ±0 | ±0% | 57,000 |
2024/03/28 | 3,585 | 3,625 | 3,505 | 3,535 | -25 | -0.7% | 80,200 |
2024/03/27 | 3,525 | 3,595 | 3,515 | 3,560 | +35 | +1% | 127,500 |
2024/03/26 | 3,495 | 3,535 | 3,475 | 3,525 | +15 | +0.4% | 87,400 |
2024/03/25 | 3,585 | 3,585 | 3,505 | 3,510 | -65 | -1.8% | 110,600 |
2024/03/22 | 3,540 | 3,575 | 3,500 | 3,575 | +55 | +1.6% | 87,800 |
2024/03/21 | 3,595 | 3,610 | 3,515 | 3,520 | -15 | -0.4% | 153,700 |
2024/03/19 | 3,595 | 3,605 | 3,495 | 3,535 | -80 | -2.2% | 117,000 |
2024/03/18 | 3,640 | 3,690 | 3,585 | 3,615 | -10 | -0.3% | 146,900 |
2024/03/15 | 3,635 | 3,670 | 3,600 | 3,625 | -35 | -1% | 310,200 |
2024/03/14 | 3,695 | 3,700 | 3,585 | 3,660 | -30 | -0.8% | 112,000 |
2024/03/13 | 3,700 | 3,720 | 3,670 | 3,690 | -10 | -0.3% | 129,900 |
2024/03/12 | 3,640 | 3,700 | 3,615 | 3,700 | +50 | +1.4% | 118,700 |
2024/03/11 | 3,575 | 3,675 | 3,550 | 3,650 | +10 | +0.3% | 132,000 |
2024/03/08 | 3,540 | 3,690 | 3,525 | 3,640 | +110 | +3.1% | 174,200 |
2024/03/07 | 3,500 | 3,535 | 3,480 | 3,530 | +50 | +1.4% | 82,400 |
2024/03/06 | 3,440 | 3,510 | 3,430 | 3,480 | +80 | +2.4% | 90,600 |
2024/03/05 | 3,415 | 3,440 | 3,400 | 3,400 | -40 | -1.2% | 84,800 |
2024/03/04 | 3,435 | 3,470 | 3,420 | 3,440 | +25 | +0.7% | 65,500 |
2024/03/01 | 3,395 | 3,420 | 3,390 | 3,415 | +20 | +0.6% | 39,600 |
2024/02/29 | 3,385 | 3,430 | 3,365 | 3,395 | +15 | +0.4% | 106,400 |
2024/02/28 | 3,380 | 3,410 | 3,350 | 3,380 | ±0 | ±0% | 85,400 |
2024/02/27 | 3,365 | 3,400 | 3,350 | 3,380 | +15 | +0.4% | 60,900 |
2024/02/26 | 3,325 | 3,375 | 3,290 | 3,365 | +80 | +2.4% | 83,300 |
2024/02/22 | 3,325 | 3,330 | 3,270 | 3,285 | -5 | -0.2% | 96,300 |
2024/02/21 | 3,315 | 3,325 | 3,265 | 3,290 | -20 | -0.6% | 95,000 |
2024/02/20 | 3,335 | 3,335 | 3,295 | 3,310 | -10 | -0.3% | 89,900 |
2024/02/19 | 3,300 | 3,330 | 3,275 | 3,320 | +40 | +1.2% | 101,000 |
2024/02/16 | 3,250 | 3,295 | 3,240 | 3,280 | +45 | +1.4% | 78,300 |
2024/02/15 | 3,265 | 3,265 | 3,195 | 3,235 | -20 | -0.6% | 87,600 |
2024/02/14 | 3,230 | 3,265 | 3,210 | 3,255 | +40 | +1.2% | 99,300 |
2024/02/13 | 3,175 | 3,215 | 3,155 | 3,215 | +65 | +2.1% | 91,900 |
251~
300
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 381,000円 | +14.5% | -2.3% | 2.36% | 13.94倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
科研薬 | 405,500円 | +30.5% | +111.0% | 4.69% | 11.43倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
サンバイオ | 231,700円 | - | - | 0.00% | - | 107.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 558,000円 | +7.1% | -35.0% | 2.15% | 46.14倍 | 1.29倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム